Shijiazhuang Yiling Pharmaceutical Co., Ltd.
002603
Rank in Stocks
#4260
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and... Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
Share Price
$2.22
Market Cap
$3.71B
Change (1 day)
-0.13%
Change (1 year)
-7.34%
Country
CN
Trade Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
Category
Healthcare
Dividend yield history for Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (stock symbol: 002603) dividend yield (TTM) as of 2023-12-31: 2.17%
Average dividend yield, last 5 years : 1.71%
Average dividend yield, last 5 years : 1.71%
Dividend yield history for Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603) from 2008 to 2026
Dividend Yield at the end of each year (TTM)
| Year | Dividend Yield | Change |
|---|---|---|
| 2026 (TTM) | 5.32% | 280.00% |
| 2024 | 1.40% | -35.48% |
| 2023 | 2.17% | 287.50% |
| 2022 | 0.56% | -84.62% |
| 2021 | 3.64% | 366.67% |
| 2020 | 0.78% | -3.70% |
| 2019 | 0.81% | -20.59% |
| 2018 | 1.02% | 72.88% |
| 2017 | 0.59% | 31.11% |
| 2016 | 0.45% | 55.17% |
| 2015 | 0.29% | -14.71% |
| 2014 | 0.34% | 9.68% |
| 2013 | 0.31% | 10.71% |
| 2012 | 0.28% | -26.32% |
| 2011 | 0.38% | 1,166.67% |
| 2010 | 0.03% | 200.00% |
| 2009 | 0.01% | -98.25% |
| 2008 | 0.57% | 0.00% |
Dividend yields (TTM) for similar companies or competitors
| Company | Dividend Yield | Country |
|---|---|---|
| 1.57% |
US
|
|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 2.29% |
HK
|
